Canada markets close in 5 hours 49 minutes

Galmed Pharmaceuticals Ltd. (GLMD)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.3676+0.0156 (+4.43%)
As of 09:46AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.20M
Enterprise Value -10.40M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.16
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 1.39

Trading Information

Stock Price History

Beta (5Y Monthly) 0.87
52-Week Change 313.55%
S&P500 52-Week Change 323.10%
52 Week High 35.6300
52 Week Low 30.2600
50-Day Moving Average 30.3619
200-Day Moving Average 30.5187

Share Statistics

Avg Vol (3 month) 3214.26k
Avg Vol (10 day) 340.78k
Shares Outstanding 56.01M
Implied Shares Outstanding 66.01M
Float 85.78M
% Held by Insiders 13.87%
% Held by Institutions 19.44%
Shares Short (Apr 15, 2024) 479.03k
Short Ratio (Apr 15, 2024) 40.18
Short % of Float (Apr 15, 2024) 41.37%
Short % of Shares Outstanding (Apr 15, 2024) 41.32%
Shares Short (prior month Mar 15, 2024) 46.21k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-28.22%
Return on Equity (ttm)-50.63%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -7.46M
Net Income Avi to Common (ttm)-6.91M
Diluted EPS (ttm)-2.5000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)12.64M
Total Cash Per Share (mrq)2.1
Total Debt (mrq)41k
Total Debt/Equity (mrq)0.29%
Current Ratio (mrq)4.81
Book Value Per Share (mrq)2.75

Cash Flow Statement

Operating Cash Flow (ttm)-6.14M
Levered Free Cash Flow (ttm)-3.63M